Focused on Exploring For Graphite and Lithium Deposits
Demand for graphite has been increasing by approximately 5 per cent per year since 2000
AGORACOM NEWS FLASH
We are very pleased to announce the authorization of the Phase I clinical trial by TPD. This is an important milestone in the clinical development of smoked Cannabis in North America and we are proud to be working with Algorithme pharma, a Clinical Research Organization with many years of experience and expertise in the conduct of Phase I clinical studies, said Dr. Chamberland, Chief Science Officer.
Message: Lomiko Appoints Rod Ogilvie P.GEO, P.ENG to the Board of Advisors
Please login to post a reply